Management strategy including hydroxyurea successful in unresectable meningioma June 24, 1998 No Comments
S-16020-2: a topoisomerase II inhibitor selective for renal cancers heads for phase II testing June 24, 1998 No Comments
Lilly presents results of first clinical trial evaluating the MDR modulator LY-335979 June 23, 1998 No Comments
Czech investigators describe novel CDK inhibitor with potent antitumor activity June 23, 1998 No Comments
SB-T-101131, a second-generation taxane with improved efficacy in MDR tumors June 22, 1998 No Comments
RSS